AG0058W1

7481-89-2 | Dideoxycytidine

Chemical structure of Dideoxycytidine, CAS 7481-89-2
AG0058W1
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 7481-89-2
Catalog Number AG0058W1(AGN-PC-0OHIUW)
Chemical Name Dideoxycytidine
IUPAC Name 4-amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
InChI InChI=1S/C9H13N3O3/c10-7-3-4-12(9(14)11-7)8-2-1-6(5-13)15-8/h3-4,6,8,13H,1-2,5H2,(H2,10,11,14)/t6-,8+/m0/s1
InChI Key WREGKURFCTUGRC-POYBYMJQSA-N
MDL Number MFCD00012188
Molecular Formula C9H13N3O3
Molecular Weight 211.2178
NSC Number 759655
SMILES NC1=NC(=O)N(C=C1)[C@H]1CC[C@@H](CO)O1
UNII 6L3XT8CB3I
Synonyms
2',3' Dideoxycytidine, 2',3'-Dideoxycytidine, ddC (Antiviral), Dideoxycytidine, Hivid, HIVID Roche, NSC 606170, NSC-606170, NSC606170, Zalcitabine, zalcitabine, 2',3'-DIDEOXYCYTIDINE, 7481-89-2, Dideoxycytidine, ddCyd, HIVID, ddC, Cytidine, 2',3'-dideoxy-, Zalcitibine, NSC 606170, 4-Amino-1-((2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, 2,3-dideoxycytidine, UNII-6L3XT8CB3I, Ro 24-2027/000, CCRIS 692, C9H13N3O3, HSDB 7156, Ro-24-2027/000, MFCD00012188, CHEMBL853, BRN 0654956, 6L3XT8CB3I, CHEBI:10101, 1-(2,3-Dideoxy-beta-D-ribofuranosyl)cytosine, WREGKURFCTUGRC-POYBYMJQSA-N, 4-amino-1-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2(1H)-one, NCGC00090705-08, DSSTox_CID_3747, ddC (Antiviral), 4-AMINO-1-[(2R,5S)-5-(HYDROXYMETHYL)OXOLAN-2-YL]-1,2-DIHYDROPYRIMIDIN-2-ONE, DSSTox_RID_77182, DSSTox_GSID_23747, 2',3'-Dideoxycytidine, 98%, NSC606170, 4-amino-1-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one, NSC-606170, SMR000058253, Hivid(TM), Zalcitabine [USAN:INN:BAN], Hivid (TN), Interferon AD + ddC, ddC & GM-CSF, ddC & sCD4, PC-SOD & ddC, Zalcitabine (JAN/USP/INN), DS-4152 & ddC, 3-[(5S,2R)-5-(hydroxymethyl)oxolan-2-yl]-6-amino-3-hydropyrimidin-2-one, ddC & NP (from PHCA or HSA), SRI-7707, Zalcitabine [USAN:USP:INN:BAN], CAS-7481-89-2, KS-1130, ddC & IFN.alpha., .beta.-D-DDC, dideoxycytidine (DDC), Prestwick0_001037, Prestwick1_001037, Prestwick2_001037, Prestwick3_001037, ddC & Interferon.alpha., 2', 3'-dideoxycytidine, bmse000712, UPCMLD-DP115, D 5782, AC1L2N6R, SCHEMBL3598, TimTec1_004969, Lopac0_000360, BSPBio_001253, 3'-Azido-3'-deoxythymidine/2',3'-Dideoxycytidine, 5-25-14-00313 (Beilstein Handbook Reference), MLS000069636, MLS000759540, MLS001055363, MLS001424210, MLS006011951, SPBio_003104, BPBio1_001378, GTPL4828, ddC|||2',3'-Dideoxycytidine, DTXSID0023747, UPCMLD-DP115:001, KS-00000MRJ, ZINC39906, 2',3'-Dideoxycytidine & sCD4(soluble recombinant protein), AOB5609, HMS1548B19, HMS1571O15, HMS2051H18, HMS2090C12, HMS2098O15, HMS2236N08, HMS3261G21, HMS3715O15, Pharmakon1600-01502360, .beta.-D-2',3'-Dideoxycytidine, Zalcitabine, 2'3'-Dideoxycytidine, BCP13878, Hivid;Dideoxycytidine;NSC 606170, Tox21_113491, Tox21_201655, Tox21_303169, Tox21_500360, 4-amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one, AC-824, ANW-36530, BDBM50145605, Lecithinized superoxide dismutase & .beta.-D-2',3'-Dideoxycytidine, NSC759655, s1719, SBB066036, Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxycytidine, AKOS015854844, AKOS015894505, Tox21_113491_1, AB01085, CCG-101050, CS-1110, DB00943, LP00360, LS-1645, MCULE-6071296177, NC00300, NSC-759655, RTC-064018, 2',3'-Dideoxycytidine & Nanoparticles (from human serum albumin or polyhexylcyanoacrylate), SRI-7707-13, SRI-7707-14, SRI-7707_15, SRI-7707_17, NCGC00090705-01, NCGC00090705-02, NCGC00090705-03, NCGC00090705-05, NCGC00090705-06, NCGC00090705-07, NCGC00090705-09, NCGC00090705-10, NCGC00090705-11, NCGC00090705-13, NCGC00090705-15, NCGC00179242-01, NCGC00257202-01, NCGC00259204-01, NCGC00261045-01, AJ-08916, AN-15472, BC203863, CPD000058253, HY-17392, K278, SAM001246779, SC-09165, ST069364, ZB001188, 2',3'-Dideoxycytidine & Interferon.alpha., 2',3'-Dideoxycytidine, >=98% (HPLC), AB0014137, AB2000246, DB-019728, Ro-242027000, TC-064018, D3581, EU-0100360, Ro-24-2027000, ST24043185, SW197364-4, 2',3'-Dideoxycytidine, >=99.0% (HPLC), C07207, D00412, M-2084, 42060-EP2295503A1, 42060-EP2298761A1, 42060-EP2305695A2, 42060-EP2305696A2, 42060-EP2305697A2, 42060-EP2305698A2, 42060-EP2311808A1, 42060-EP2311829A1, 78798-EP2298783A1, 78798-EP2305695A2, 78798-EP2305696A2, 78798-EP2305697A2, 78798-EP2305698A2, Cytidine, 2',3'-dideoxy- & Interferon.alpha., 481D892, SR-01000075822, SR-01000736919, J-700276, Q-201941, SR-01000075822-1, SR-01000736919-5, Cytidine, 2',3'-dideoxy- & Colony-stimulating factor, Ro-242027000/Ro-24-2027-000, Z1550648753, Zalcitabine, United States Pharmacopeia (USP) Reference Standard, 4-Amino-1-(5-hydroxymethyl-tetrahydro-furan-2-yl)-1H-pyrimidin-2-one, .beta.-D-2',3'-Dideoxycytidine & Granulocyte-macrophage colony-stimulating factor, Zalcitabine(DDC), HIVID Roche, Beta-D-DDC, DdC & IFN-alpha, DdC & Interferon alpha, 2',3' Dideoxycytidine, D0DC7N, D0M1YO, D0Z9QR, DDC (DDC), Zalcitabine [USAN:BAN:INN], CID24066, C9-H13-N3-O3, BETA-D-2',3'-DIDEOXYCYTIDINE, CS-O-01403, 2',3'-Dideoxycytidine & Interferon-alpha, B2223, Cytidine, 2',3'-dideoxy & Interferon alpha, 2',3'-DIDEOXYCYTIDINE-5'-MONOPHOSPHATE, D016047, Hivid, Dideoxycytidine, NSC 606170, Zalcitabine, Cytidine, 2',3'-dideoxy-& Colony-stimulating factor, Beta-D-2',3'-Dideoxycytidine & Granulocyte-macrophage colony-stimulating factor, 107-95-9, D2C, DOC,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited